{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:54:15Z","timestamp":1790855655285,"version":"4.1.0"},"reference-count":48,"publisher":"Wiley","issue":"1pt2","license":[{"start":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T00:00:00Z","timestamp":1237766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Experimental autoimmune myasthenia gravis (EAMG), an animal model of myasthenia gravis (MG), is a rare organ\u2010specific autoimmune disease targeting the autoantigen nicotinic acetylcholine receptor (AChR). We show here that the balance of T helper type 1 (Th1), Th2, Th17 and regulatory T (Treg) subsets of CD4<jats:sup>+<\/jats:sup> helper T cells were redistributed during the development of EAMG and that the interleukin\u201017 (IL\u201017) cytokine is involved in this disease. The ratio of Th17 cells changed most notably with disease progression accompanied by an up\u2010regulated level of IL\u201017. Moreover, the proliferative ability of AChR peptide\u2010specific T cells and the anti\u2010AChR antibody\u2010secreting cells increased when stimulated by IL\u201017 <jats:italic>in vitro<\/jats:italic>. These findings suggested that the disequilibrium of the CD4<jats:sup>+<\/jats:sup> helper T\u2010cell subsets could promote the development of EAMG, and the pathogenic mechanism by which Th17 cells drives autoimmune responses by secreting cytokine IL\u201017 provides a new target for myasthenia gravis therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2567.2009.03089.x","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T14:53:42Z","timestamp":1237820022000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis"],"prefix":"10.1111","volume":"128","author":[{"given":"Lili","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixia","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04232.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/08916930500124122"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.099192"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03283.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v25.i2.10"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04753"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04754"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.06.002"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061341"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.1.566"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1430"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01355"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041257"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030896"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120300678828703"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.1.577"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000058399"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01602.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0502-500"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00391-6"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.11.6173"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1035999100"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2008.05.022","article-title":"Acetylcholinesterase inhibitors and cholinergic modulation in myasthenia gravis and neuroinflammation","volume":"202","author":"Brenner T","year":"2008","journal-title":"J Neuroimmunol"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4807"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.7072"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.4.2697"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199808)21:8<1071::AID-MUS13>3.0.CO;2-X"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.6.3136"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2000.4850"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.2.547"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.3.385"},{"key":"e_1_2_7_34_2","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.4049\/jimmunol.161.6.2856","article-title":"The Th2 cytokine IL\u20104 is not required for the progression of antibody\u2010dependent autoimmune myasthenia gravis","volume":"161","author":"Balasa B","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.07.004"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.032"},{"key":"e_1_2_7_37_2","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.4049\/jimmunol.162.12.7189","article-title":"Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1\u2010 or Th2\u2010type immune response in rats","volume":"162","author":"Saoudi A","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.12.7898"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.4.2132"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2006.03.017"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2006.05.009"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1551"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.7849"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328304b6b5"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.08.018"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3280eec78c"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210429200"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01236.x"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1552"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2567.2009.03089.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2567.2009.03089.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:11:45Z","timestamp":1697325105000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2567.2009.03089.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,4]]},"references-count":48,"journal-issue":{"issue":"1pt2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-2567.2009.03089.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03089.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,4]]},"assertion":[{"value":"2009-08-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}